Product Information
ELLA 30 MG TABLET is a brand product labeled by HRA PHARMA AMERICA, INC., priced at $37.0944 per EA under NDC 73302045601. Its NADAC has been published 302 times since Sep 16, 2020.
Strength
30 mg/1
Manufacturer
HRA PHARMA AMERICA, INC.NDC
73302045601
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ULIPRISTAL ACETATEApproval Type
New Drug (NDA)
FDA Application
NDA022474On Market Since
5/11/2020
Pharmacological Classes
Price Statistics
The NADAC for ELLA 30 MG TABLET has been published 302 times since Sep 16, 2020, and over the history we have for it it has risen 7.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $37.0944 per EA |
|---|---|
| All-time high | $37.3736 (Apr 13, 2022) |
| All-time low | $34.2750 (Feb 17, 2021) |
| 52-week high | $37.1677 |
| 52-week low | $37.0880 |
| Median price | $37.1920 |
| Average price | $36.8248 |
| Largest weekly change | +8.4% (Jul 7, 2021) |
| Weeks tracked | 302 |
| Tracking since | Sep 16, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the ulipristal acetate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ELLA 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ELLA 30 MG TABLET, manufactured by HRA PHARMA AMERICA, INC., is $37.0944 per EA (NDC 73302045601), effective Jun 24, 2026.
How has the price of ELLA 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for ELLA 30 MG TABLET has risen 7.8%. It has been tracked across 302 weekly CMS publications since Sep 16, 2020.
What are the highest and lowest recorded NADAC prices for ELLA 30 MG TABLET?
Since Sep 16, 2020, the NADAC for ELLA 30 MG TABLET has ranged from a low of $34.2750 (Feb 17, 2021) to a high of $37.3736 (Apr 13, 2022), with a median of $37.1920 per EA.
Are there cheaper alternatives to ELLA 30 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ELLA 30 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures ELLA 30 MG TABLET?
ELLA 30 MG TABLET (NDC 73302045601) is labeled by HRA PHARMA AMERICA, INC., and CMS classifies it as a brand product.
Related Drugs
Same classification